Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · August 04, 2020

Hydroxychloroquine ± Azithromycin in Mild to Moderate COVID-19

The New England Journal of Medicine

 

Additional Info

The New England Journal of Medicine
Hydroxychloroquine With or Without Azithromycin in Mild-to-Moderate Covid-19
N. Engl. J. Med 2020 Jul 23;[EPub Ahead of Print], AB Cavalcanti, FG Zampieri, RG Rosa, LCP Azevedo, VC Veiga, A Avezum, LP Damiani, A Marcadenti, L Kawano-Dourado, T Lisboa, DLM Junqueira, PGM de Barros e Silva, L Tramujas, EO Abreu-Silva, LN Laranjeira, AT Soares, LS Echenique, AJ Pereira, FGR Freitas, OCE Gebara, VCS Dantas, RHM Furtado, EP Milan, NA Golin, FF Cardoso, IS Maia, CR Hoffmann Filho, APM Kormann, RB Amazonas, MF Bocchi de Oliveira, A Serpa-Neto, M Falavigna, RD Lopes, FR Machado, O Berwanger

Further Reading